These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9822136)

  • 1. Natural history of cardiovascular and renal disease in patients with type 2 diabetes: effect of therapeutic interventions and risk modification.
    Mogensen CE
    Am J Cardiol; 1998 Nov; 82(9B):4R-8R. PubMed ID: 9822136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia in patients with type 2 diabetes. relationships between lipids, kidney disease and cardiovascular disease.
    Battisti WP; Palmisano J; Keane WE
    Clin Chem Lab Med; 2003 Sep; 41(9):1174-81. PubMed ID: 14598867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines.
    Mooradian AD
    Arch Intern Med; 2003 Jan; 163(1):33-40. PubMed ID: 12523914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forum One: Current recommendations about intensification of metabolic control in non-insulin-dependent diabetes mellitus.
    Henry RR; Genuth S
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):175-7. PubMed ID: 8554214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?
    Khunti K; Kosiborod M; Ray KK
    Diabetes Obes Metab; 2018 Jun; 20(6):1337-1341. PubMed ID: 29405543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus document of the Spanish Society of Arteriosclerosis (SEA) for the prevention and treatment of cardiovascular disease in type 2 diabetes mellitus.
    Ruiz-García A; Arranz-Martínez E; Morón-Merchante I; Pascual-Fuster V; Tamarit JJ; Trias-Villagut F; Pintó-Sala X; Ascaso JF;
    Clin Investig Arterioscler; 2018 Jul; 30 Suppl 1():1-19. PubMed ID: 30053980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is the most effective approach to the reduction of cardiovascular risk in type-2 diabetes mellitus?].
    Simon K; Dobó E; Nádasy T; Retih I; Rácz I
    Orv Hetil; 2006 Aug; 147(31):1443-6. PubMed ID: 16981416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of diabetes in cardiovascular patients: diabetic heart disease.
    Peter R; Cox A; Evans M
    Heart; 2008 Mar; 94(3):369-75. PubMed ID: 18276822
    [No Abstract]   [Full Text] [Related]  

  • 11. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors in type 2 diabetic patients: multifactorial intervention in primary care.
    Tranche S; Galgo A; Mundet X; Sánchez-Zamorano MA;
    Kidney Int Suppl; 2005 Jan; (93):S55-62. PubMed ID: 15613070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive treatment and multifactorial approach for renal protection in diabetes.
    Fioretto P; Solini A
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S18-21. PubMed ID: 15938027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing cardiovascular risk in diabetes. Which factors to modify first?
    Spanheimer RG
    Postgrad Med; 2001 Apr; 109(4):26-30, 33-6. PubMed ID: 11317467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
    Zarich SW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S19-28. PubMed ID: 14668700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register.
    Afghahi H; Svensson MK; Pirouzifard M; Eliasson B; Svensson AM
    Diabetologia; 2015 Jun; 58(6):1203-11. PubMed ID: 25773403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy.
    Spallarossa P; Barsotti A; Cordera R; Ghigliotti G; Maggi D; Brunelli C
    J Endocrinol Invest; 2004 May; 27(5):485-95. PubMed ID: 15279085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes.
    Lteif AA; Mather KJ; Clark CM
    Cardiol Rev; 2003; 11(5):262-74. PubMed ID: 12943604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.